Correlation Between Allarity Therapeutics and GT Biopharma
Can any of the company-specific risk be diversified away by investing in both Allarity Therapeutics and GT Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allarity Therapeutics and GT Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Allarity Therapeutics and GT Biopharma, you can compare the effects of market volatilities on Allarity Therapeutics and GT Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allarity Therapeutics with a short position of GT Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allarity Therapeutics and GT Biopharma.
Diversification Opportunities for Allarity Therapeutics and GT Biopharma
0.37 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Allarity and GTBP is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Allarity Therapeutics and GT Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GT Biopharma and Allarity Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allarity Therapeutics are associated (or correlated) with GT Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GT Biopharma has no effect on the direction of Allarity Therapeutics i.e., Allarity Therapeutics and GT Biopharma go up and down completely randomly.
Pair Corralation between Allarity Therapeutics and GT Biopharma
Given the investment horizon of 90 days Allarity Therapeutics is expected to generate 1.52 times more return on investment than GT Biopharma. However, Allarity Therapeutics is 1.52 times more volatile than GT Biopharma. It trades about 0.04 of its potential returns per unit of risk. GT Biopharma is currently generating about -0.25 per unit of risk. If you would invest 111.00 in Allarity Therapeutics on November 3, 2024 and sell it today you would earn a total of 1.00 from holding Allarity Therapeutics or generate 0.9% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Allarity Therapeutics vs. GT Biopharma
Performance |
| Timeline |
| Allarity Therapeutics |
| GT Biopharma |
Allarity Therapeutics and GT Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Allarity Therapeutics and GT Biopharma
The main advantage of trading using opposite Allarity Therapeutics and GT Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allarity Therapeutics position performs unexpectedly, GT Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GT Biopharma will offset losses from the drop in GT Biopharma's long position.| Allarity Therapeutics vs. Immix Biopharma | Allarity Therapeutics vs. Cns Pharmaceuticals | Allarity Therapeutics vs. Sonnet Biotherapeutics Holdings | Allarity Therapeutics vs. Zura Bio Limited |
| GT Biopharma vs. Allarity Therapeutics | GT Biopharma vs. Virax Biolabs Group | GT Biopharma vs. Quoin Pharmaceuticals Ltd | GT Biopharma vs. Virpax Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |